SCHEMBL5142126

SCHEMBL5142126

O=C1CC(=O)n2c(nc3ccccc32)N1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HPGD P15428 2/20 0.47
MAPT P10636 1/20 0.45
LMNA P02545 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RAB9A P51151 2/20 0.41
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ADAMTS5 Q9UNA0 1/20 0.40
TSHR P16473 1/20 0.39
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
KDM4E B2RXH2 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1699146 0.73 TSHR (0.47) ALDH1A1MEN1KMT2AHPGDCYP2C19
SCHEMBL8797169 0.73 ALPI (0.41) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL1713613 0.71 CRBN (0.44) ALDH1A1HPGDTSHRDDB1CRBN
SCHEMBL32688313 0.71 CRBN (0.44) ALDH1A1HPGDTSHRDDB1CRBN
SCHEMBL10986913 0.68 RAB9A (0.41) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL29802292 0.67 RAB9A (0.59) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL28815924 0.67 RAB9A (0.59) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL9255441 0.66 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL8729916 0.66 TSHR (0.46) ALDH1A1MEN1KMT2AHPGDMAPT
SCHEMBL10977453 0.65 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070264600-A1 Heterocyclic Colorants Based on Diazabenzoisoindoles CLARIANT GMBH (DE) 2007-11-15 US disclosed
EP-0297397-B1 PREPARATION OF DIAZO AND AZO COMPOUNDS BAYER AG (DE) 1993-08-04 EP disclosed
US-4942225-A Preparation of diazo and azo compounds using azidoformamidium salts BAYER AKTIENGESELLSCHAFT (DE) 1990-07-17 US disclosed
EP-0297397-A2 Preparation of diazo and azo compounds BAYER AG (DE) 1989-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070264600-A1 Heterocyclic Colorants Based on Diazabenzoisoindoles DDT, CDK4, CDK13 ALDH1A1 120/4885MEN1 1782/4885KMT2A 1153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.